Michael Bergeron is VP at Dolby Laboratories, Inc. (DLB). They have made 8 open-market trades across 1 company since 2014, most recently 2016-08-16.
CIK 0001308547
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DLB | 34,940 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2016-08-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DLB | SELL | 2016-08-16 | 2016-08-18 | $49.10 | $2.5M | -1.3% | +3.0% | -4.6% |
| DLB | SELL | 2016-08-16 | 2016-08-18 | $49.10 | $4.8M | -1.3% | +3.0% | -4.6% |
| DLB | SELL | 2016-08-10 | 2016-08-10 | $49.67 | $864K | +0.6% | -1.9% | -4.5% |
| DLB | SELL | 2016-08-09 | 2016-08-10 | $49.84 | $3.4M | +0.6% | -1.9% | -4.5% |
| DLB | SELL | 2016-08-09 | 2016-08-10 | $49.90 | $2.5M | +0.6% | -1.9% | -4.5% |
| DLB | SELL | 2016-05-17 | 2016-05-18 | $45.02 | $4.5M | +6.9% | +5.7% | +10.5% |
| DLB | SELL | 2016-05-17 | 2016-05-18 | $45.02 | $2.3M | +6.9% | +5.7% | +10.5% |
| DLB | SELL | 2014-08-13 | 2014-08-14 | $45.67 | $62K | -6.2% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.